Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C43H74N2O14 |
Molecular Weight | 843.0527 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 19 / 19 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]1(C[C@@](C)(O)[C@@H](O)[C@H](C)O1)O[C@@H]2[C@@H](C)O[C@@]([H])(O[C@H]3[C@@H](CC=O)C[C@@H](C)[C@@H](O[C@@]4([H])CC[C@@H]([C@@H](C)O4)N(C)C)\C=C\C=C\C[C@@H](C)OC(=O)C[C@@H](O)[C@@H]3OC)[C@H](O)[C@H]2N(C)C
InChI
InChIKey=ACTOXUHEUCPTEW-CEUOBAOPSA-N
InChI=1S/C43H74N2O14/c1-24-21-29(19-20-46)39(59-42-37(49)36(45(9)10)38(27(4)56-42)58-35-23-43(6,51)41(50)28(5)55-35)40(52-11)31(47)22-33(48)53-25(2)15-13-12-14-16-32(24)57-34-18-17-30(44(7)8)26(3)54-34/h12-14,16,20,24-32,34-42,47,49-51H,15,17-19,21-23H2,1-11H3/b13-12+,16-14+/t24-,25-,26-,27-,28+,29+,30+,31-,32+,34+,35+,36-,37-,38-,39+,40+,41+,42+,43-/m1/s1
Molecular Formula | C43H74N2O14 |
Molecular Weight | 843.0527 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 19 / 19 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/17849607
Sources: https://www.ncbi.nlm.nih.gov/pubmed/17849607
Spiramycins are macrolides produced by cultures of Streptomyces ambofaciens from the soil of northern France. The mixture of spiramycins have been successfully separated into three different components termed as Spiramycin I, II and III, which differ structurally in the acylation moieties on the C3 of the lactone. The SP I component contains a hydroxyl group at C3. The drug is effective against gram-positive aerobic pathogens, N. gonorrhoeae, and staphylococci. It is used to treat infections caused by bacteria and Toxoplasma gondii.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:54:36 UTC 2023
by
admin
on
Fri Dec 15 15:54:36 UTC 2023
|
Record UNII |
033ECH6IFG
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
85260
Created by
admin on Fri Dec 15 15:54:36 UTC 2023 , Edited by admin on Fri Dec 15 15:54:36 UTC 2023
|
PRIMARY | |||
|
2471
Created by
admin on Fri Dec 15 15:54:36 UTC 2023 , Edited by admin on Fri Dec 15 15:54:36 UTC 2023
|
PRIMARY | |||
|
033ECH6IFG
Created by
admin on Fri Dec 15 15:54:36 UTC 2023 , Edited by admin on Fri Dec 15 15:54:36 UTC 2023
|
PRIMARY | |||
|
C017186
Created by
admin on Fri Dec 15 15:54:36 UTC 2023 , Edited by admin on Fri Dec 15 15:54:36 UTC 2023
|
PRIMARY | |||
|
m10149
Created by
admin on Fri Dec 15 15:54:36 UTC 2023 , Edited by admin on Fri Dec 15 15:54:36 UTC 2023
|
PRIMARY | Merck Index | ||
|
DTXSID9023594
Created by
admin on Fri Dec 15 15:54:36 UTC 2023 , Edited by admin on Fri Dec 15 15:54:36 UTC 2023
|
PRIMARY | |||
|
5289394
Created by
admin on Fri Dec 15 15:54:36 UTC 2023 , Edited by admin on Fri Dec 15 15:54:36 UTC 2023
|
PRIMARY | |||
|
24916-50-5
Created by
admin on Fri Dec 15 15:54:36 UTC 2023 , Edited by admin on Fri Dec 15 15:54:36 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |